Madhu Eluri, MD (@madhueluri) 's Twitter Profile
Madhu Eluri, MD

@madhueluri

GI Medical Oncologist at MD Anderson Cancer Center. Opinions my own. Follow me on Instagram @gi.onc.doc

ID: 936422188219097088

linkhttps://www.nameshouts.com/names/hindi/pronounce-madhu calendar_today01-12-2017 02:30:22

531 Tweet

1,1K Followers

629 Following

Eric K. Singhi, MD (@lungoncdoc) 's Twitter Profile Photo

#ASCO24 is all about branching out from your subspecialty because knowledge conquers cancer! Madhu Eluri, MD presenting exciting work in the colorectal cancer space!! 🔥MD Anderson Cancer Center #EndCancer

#ASCO24 is all about branching out from your subspecialty because knowledge conquers cancer! 

<a href="/MadhuEluri/">Madhu Eluri, MD</a> presenting exciting work in the colorectal cancer space!! 🔥<a href="/MDAndersonNews/">MD Anderson Cancer Center</a> #EndCancer
Madhu Eluri, MD (@madhueluri) 's Twitter Profile Photo

In light of @ccaalliance #YoungSurvivorsWeek, a summary of the American Cancer Society paper on colorectal cancer trends in the United States and the rise of young-onset CRC. Full article here: acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… #crcsm #ayacsm

Anirban Maitra (@aiims1742) 's Twitter Profile Photo

#OpenAccess in Nature Medicine Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic #ColorectalCancer: a phase 1 trial nature.com/articles/s4159… This paper is generating a lot of excitement because of MSS CRC, but important to remember that

#OpenAccess in <a href="/NatureMedicine/">Nature Medicine</a> 
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic #ColorectalCancer: a phase 1 trial
nature.com/articles/s4159…
This paper is generating a lot of excitement because of MSS CRC, but important to remember that
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Research led by Drs. Kaysia Ludford and Michael Overman highlights pembrolizumab's potential for long-term cancer control and organ preservation in some cancer patients. Read more about the findings presented at #ESMO24: bit.ly/3z0Mg2M Michael overman #EndCancer

Research led by Drs. Kaysia Ludford and Michael Overman highlights pembrolizumab's potential for long-term cancer control and organ preservation in some cancer patients. 

Read more about the findings presented at #ESMO24: bit.ly/3z0Mg2M <a href="/michael_overman/">Michael overman</a> #EndCancer
Madhu Eluri, MD (@madhueluri) 's Twitter Profile Photo

My favorite topic 🧬🧬, the battle 🗣️between utility of ctDNA in cholangiocarcinoma between Dr. Caron Jia and Laura Goff #CCA2024 ⁃Concordance for mutations b/w ctDNA and tissue is high , but limitations exist esp for fusions ⁃negative ctDNA still requires tissue confirm

My favorite topic 🧬🧬, the battle 🗣️between utility of ctDNA in cholangiocarcinoma between Dr. Caron Jia and <a href="/drlauragoff/">Laura Goff</a> #CCA2024

⁃Concordance for mutations b/w ctDNA and tissue is high , but limitations exist esp for fusions 
⁃negative ctDNA still requires tissue confirm
Madhu Eluri, MD (@madhueluri) 's Twitter Profile Photo

Excited for the first ever Houston Cholangiocarcinoma Foundation Symposium. Hearing about the incredible efforts by the one and only Milind Javle over the past 2 decades for patients with biliary tract cancer.

Excited for the first ever Houston <a href="/curecc/">Cholangiocarcinoma Foundation</a> Symposium. Hearing about the incredible efforts by the one and only <a href="/JavleMilind/">Milind Javle</a> over the past 2 decades for patients with biliary tract cancer.